153 related articles for article (PubMed ID: 31800162)
1. Importance of PNO1 for growth and survival of urinary bladder carcinoma: Role in core-regulatory circuitry.
Lin C; Yuan H; Wang W; Zhu Z; Lu Y; Wang J; Feng F; Wu J
J Cell Mol Med; 2020 Jan; 24(2):1504-1515. PubMed ID: 31800162
[TBL] [Abstract][Full Text] [Related]
2. Pien Tze Huang Inhibits Proliferation of Colorectal Cancer Cells through Suppressing PNO1 Expression and Activating p53/p21 Signaling Pathway.
Cao LJ; Liu LY; Chen YQ; Han YY; Wei LH; Yao MY; Fang Y; Wu MZ; Cheng Y; Sferra TJ; Liu HX; Li L; Peng J; Shen AL
Chin J Integr Med; 2024 Jun; 30(6):515-524. PubMed ID: 38216838
[TBL] [Abstract][Full Text] [Related]
3. EBF1-Mediated Upregulation of Ribosome Assembly Factor PNO1 Contributes to Cancer Progression by Negatively Regulating the p53 Signaling Pathway.
Shen A; Chen Y; Liu L; Huang Y; Chen H; Qi F; Lin J; Shen Z; Wu X; Wu M; Li Q; Qiu L; Yu N; Sferra TJ; Peng J
Cancer Res; 2019 May; 79(9):2257-2270. PubMed ID: 30862720
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of PNO1 inhibits esophageal cancer progression.
Wang G; Li Q; Li C; Duan G; Sang H; Dong H; Yang Y; Ma C; Tao T
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33864661
[TBL] [Abstract][Full Text] [Related]
5. Celecoxib Inhibits Hepatocellular Carcinoma Cell Growth and Migration by Targeting PNO1.
Dai H; Zhang S; Ma R; Pan L
Med Sci Monit; 2019 Sep; 25():7351-7360. PubMed ID: 31568401
[TBL] [Abstract][Full Text] [Related]
6. Ribosome assembly factor PNO1 is associated with progression and promotes tumorigenesis in triple‑negative breast cancer.
Li J; Liu L; Chen Y; Wu M; Lin X; Shen Z; Cheng Y; Chen X; Weygant N; Wu X; Wei L; Sferra TJ; Han Y; Chen X; Shen A; Shen A; Peng J
Oncol Rep; 2022 Jun; 47(6):. PubMed ID: 35445733
[TBL] [Abstract][Full Text] [Related]
7. MYC-mediated upregulation of PNO1 promotes glioma tumorigenesis by activating THBS1/FAK/Akt signaling.
Chen X; Guo ZQ; Cao D; Chen Y; Chen J
Cell Death Dis; 2021 Mar; 12(3):244. PubMed ID: 33664245
[TBL] [Abstract][Full Text] [Related]
8. PNO1 promotes the progression of osteosarcoma via TGF-β and YAP/TAZ pathway.
Fang L; Wang B; Yang Z; Zhao T; Hao W
Sci Rep; 2023 Dec; 13(1):21827. PubMed ID: 38071381
[TBL] [Abstract][Full Text] [Related]
9. Partner of NOB1 homolog transcriptionally activated by E2F transcription factor 1 promotes the malignant progression and inhibits ferroptosis of pancreatic cancer.
Yang Q; Yang B; Chen M
Chin J Physiol; 2023; 66(5):388-399. PubMed ID: 37929351
[TBL] [Abstract][Full Text] [Related]
10. CBX7 suppresses urinary bladder cancer progression via modulating AKR1B10-ERK signaling.
Huang Z; Yan Y; Zhu Z; Liu J; He X; Dalangood S; Li M; Tan M; Cai J; Tang P; Huang R; Shen B; Yan J
Cell Death Dis; 2021 May; 12(6):537. PubMed ID: 34035231
[TBL] [Abstract][Full Text] [Related]
11. High expression of TMEM40 is associated with the malignant behavior and tumorigenesis in bladder cancer.
Zhang ZF; Zhang HR; Zhang QY; Lai SY; Feng YZ; Zhou Y; Zheng SR; Shi R; Zhou JY
J Transl Med; 2018 Jan; 16(1):9. PubMed ID: 29351801
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of ribosome assembly factor PNO1 by CRISPR/Cas9 technique suppresses lung adenocarcinoma and Notch pathway: Clinical application.
Roy SK; Srivastava S; Hancock A; Shrivastava A; Morvant J; Shankar S; Srivastava RK
J Cell Mol Med; 2023 Feb; 27(3):365-378. PubMed ID: 36625087
[TBL] [Abstract][Full Text] [Related]
13. CCDC34 is up-regulated in bladder cancer and regulates bladder cancer cell proliferation, apoptosis and migration.
Gong Y; Qiu W; Ning X; Yang X; Liu L; Wang Z; Lin J; Li X; Guo Y
Oncotarget; 2015 Sep; 6(28):25856-67. PubMed ID: 26312564
[TBL] [Abstract][Full Text] [Related]
14. QKI-6 inhibits bladder cancer malignant behaviours through down-regulating E2F3 and NF-κB signalling.
Shi F; Deng Z; Zhou Z; Jiang CY; Zhao RZ; Sun F; Cui D; Bei XY; Yang BY; Sun Q; Wang XJ; Wu Q; Xia SJ; Han BM
J Cell Mol Med; 2019 Oct; 23(10):6578-6594. PubMed ID: 31449345
[TBL] [Abstract][Full Text] [Related]
15. ZSCAN16 promotes proliferation, migration and invasion of bladder cancer via regulating NF-kB, AKT, mTOR, P38 and other genes.
Li X; Shang D; Shen H; Song J; Hao G; Tian Y
Biomed Pharmacother; 2020 Jun; 126():110066. PubMed ID: 32172065
[TBL] [Abstract][Full Text] [Related]
16. Pno1 tissue-specific expression and its functions related to the immune responses and proteasome activities.
Wang X; Wu T; Hu Y; Marcinkiewicz M; Qi S; Valderrama-Carvajal H; Luo H; Wu J
PLoS One; 2012; 7(9):e46093. PubMed ID: 23029399
[TBL] [Abstract][Full Text] [Related]
17. Circular RNA DOCK1 promotes bladder carcinoma progression via modulating circDOCK1/hsa-miR-132-3p/Sox5 signalling pathway.
Liu P; Li X; Guo X; Chen J; Li C; Chen M; Liu L; Zhang X; Zu X
Cell Prolif; 2019 Jul; 52(4):e12614. PubMed ID: 30983072
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of CIT can inhibit the growth of human bladder cancer cells.
Liu Z; Yan H; Yang Y; Wei L; Xia S; Xiu Y
Biomed Pharmacother; 2020 Apr; 124():109830. PubMed ID: 31972359
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of HMGN5 suppresses the viability and invasion of human urothelial bladder cancer 5637 cells in vitro and in vivo.
Gan Y; Tan J; Yang J; Zhou Y; Dai Y; He L; Yao K; Tang Y
Med Oncol; 2015 Apr; 32(4):136. PubMed ID: 25796505
[TBL] [Abstract][Full Text] [Related]
20. The long noncoding RNA ZFAS1 facilitates bladder cancer tumorigenesis by sponging miR-329.
Wang JS; Liu QH; Cheng XH; Zhang WY; Jin YC
Biomed Pharmacother; 2018 Jul; 103():174-181. PubMed ID: 29653362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
